Medicinal Product Shortages – update – 20 April 2022

Notice type: Advisory

Date: 20/04/2022


Further Information:

 The Health Products Regulatory Authority has been notified of a shortage of the following products:

  • Adrenaline (Epinephrine) 1mg/10 ml (1:10,000) Solution for Injection in Pre Filled Syringe - PA1968/002/001
  • Emizof 8mg Film Coated Tablets - PA0577/083/002
  • EpiPen 300mcg Solution for Injection in Pre Filled Pen - PA2010/062/002
  • Metalyse 50mg Powder and Solvent for Solution for Injection - EU/1/00/169/006
  • Seroxat 20mg/10ml Oral Solution - PA1077/097/001
  • Telfast Allergy 120mg Film Coated Tablets - PA23180/014/001
  • Triapin 2.5mg/2.5mg Prolonged Release Tablet - PA0540/082/001
  • Tobi 300mg/5ml Nebuliser Solution - PA2010/063/001
  • Vokanamet 50mg/850mg Film Coated Tablets - EU/1/14/918/002


The following shortages have been resolved and supply has resumed to the Irish market:

  • Arcoxia 60mg Tablets - PA0964/009/002
  • Orencia 125mg/ml Solution for Injection Pre Filled Pen - EU/1/07/389/011
  • Skilarence 30mg Gastro Resistant Tablets - EU/1/17/1201/001


Please see the shortages section of the HPRA website for further information.

The HPRA sends weekly updates concerning medicinal product shortages. However, the above webpage will be updated as new information is provided to the HPRA.

« Back